Aristotle University Of Thessaloniki (AUTH)
Φαρμακοκινητική μελέτη του συνδυασμού πακλιταξέλης και καρβοπλατίνης σε καρκινοπαθείς
Abstract
dc:descriptionPurpose: To investigate the pharmacokinetics of paclitaxel when is administered in combination with carboplatin in patients with advanced cancer. Patients and Methods: Thirty-two patients, 16 with metastatic breast cancer and 16 with locally-advanced or metastatic head and neck cancer were entered onto the pharmacokinetic study, in which paclitaxel was administered as a 3-hour infusion at a dose of 200 mg/m2 and carboplatin over 30 min, at an AUC of 7 mg/mL-min, immediately after paclitaxel, with GCSF support on days 2-12 of the cycle. Paclitaxel and platinum were quantified by high-performance-liquid chromatography (HPLC) and atomic absorption spectrophotometry respectively. Pharmacokinetics were assessed by model-dependent methods. Results and conclusions: The plasma pharmacokinetics of both drugs could be described for the post infusion period by the two-compartment model. The mean AUC for paclitaxel and carboplatin were 79,48 μmol/L.h ± 32,22 and 5,99 mg/L-min ± 1,88 respectively. Paclitaxel mean AUC was higher comparative with other studies of single-agent paclitaxel, as 3-hour infusion, at dosages of 175 and 225 mg/m2. This difference may indicate a possible interaction between paclitaxel and carboplatin. The observed carboplatin AUC was consistently below the target AUC value by 10% to 15% for half of treated patients (47%). This represented either a paclitaxel carboplatin interaction or a systematic under dosing of carboplatin due to GFR underestimation. Statistical analysis by regression models did not reveal any statistical significant correlations between pharmacokinetic parameters of both studied drugs and certain patients' characteristics such as: age, gender, previous chemotherapy, performance status, hepatic metastases, and abnormal AST, ALT and alkaline phosphatase values. Possible pharmacokinetic interactions between paclitaxel and carboplatin need further investigation by pharmacokinetic studies designed to address this question.
Degree
thesis:*- Grantor dc:publisher
- Aristotle University Of Thessaloniki (AUTH)
- Year dc:date
- 2002
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Athanasiadis, Athanassios
- Αθανασιάδης, Αθανάσιος
Subjects
dc:subject × 16Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/13396